New study brings hope to heart patients

New study brings hope to heart patients
New study brings hope to heart patients

Heart disease is a chronic problem that threatens life, so scientists are always seeking solutions and treatments that reduce the risks of heart disease, and according to Deutsche Welle, "Voice of Germany", scientists were able during a study to identify several defective genes that cause a number of diseases Genetic heart.

And it could be that the world's first treatment for hereditary heart diseases could soon be within reach, as a global team of heart experts from the UK, US and Singapore are collaborating on a project called CureHeart to develop effective gene therapies for hereditary cardiomyopathy.

This project is expected to treat countless people with conditions that result in the heart being completely unable to pump blood to all parts of the body, and the team recently received a grant of nearly $ 37 million from the British Heart Foundation to support research into potentially life-saving treatments. The lives of millions around the world.

During the research, scientists will use precise genetic techniques in the heart for the first time, called basic and primary editing, to design and test the first treatment for hereditary heart muscle diseases, with the aim of stopping faulty genes from working and preventing them from producing harmful genetic mutations that cause hereditary heart diseases.

While the researchers have not yet reached the stage of clinical human trials, the signs of the treatment so far are very promising, after the trials have already seen success at the animal level, scientists told the British newspaper, "The Guardian".

Most cases of heart disease are currently incurable, but they can be controlled, says Dr. Richard Wright, a cardiologist at Providence Saint John's Prevention Health Center in Santa Monica, California.

There are several pathological cases in which a specific gene with abnormal activity was identified and identified, so there is a potential opportunity, in theory, to go directly to the cell and fix the underlying problem in these people and thus cure them.

Doctors say that all those with hereditary cardiomyopathy, also known as hereditary cardiomyopathy, have a 50:50 risk of passing the faulty gene to each of their children, and often many members of the same family will develop heart failure or need a heart transplant or transplant. They die at an early age.

Professor Hugh Watkins, from the University of Oxford and lead researcher on the CureHeart project, tells the Guardian that cardiomyopathy is a very common disease that affects 1 in 250 people worldwide.


It is our once-in-a-generation opportunity to ease the continuing anxiety within families about sudden death, heart failure and the potential need for a heart transplant, he added, adding that after 30 years of research, we have discovered many specific genes and genetic defects responsible for different cardiomyopathy, how they work, and today we believe we will have a gene therapy ready to begin testing in clinical trials in the next five years.

What is congestive heart failure?

Post a Comment

* Please Don't Spam Here. All the Comments are Reviewed by Admin.